Skip to main content

Table 4 Incident rates for severe exacerbations and purchases of systemic corticosteroids or antibiotics during follow-up stratified by respiratory hospitalizations in history

From: Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study

Stratifying variable: Number of respiratory hospitalizations in historya

Severe exacerbations

Systemic corticosteroids

Systemic antibiotics

0

0.15 (0.15-0.16)

1.05 (1.04-1.05)

1.26 (1.25-1.27)

1-2

0.74 (0.72-0.76)

2.48 (2.45-2.51)

2.03 (2.01-2.06)

3-5

2.29 (2.22-2.37)

4.57 (4.47-4.68)

3.18 (3.09-3.28)

>5

5.56(5.29-5.83)

8.38 (8.05-8.72)

4.53 (4.29-4.78)

  1. aOne year prior to follow-up. Incidence rates presented by mean value and 95% confidence interval